Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Regeneron Shareholders Watching Optina Trial Closely
Regeneron Shareholders Watching Optina Trial Closely
Regeneron Shareholders Watching Optina Trial Closely
Submitted by
admin
on May 23, 2013 - 11:32am
Source:
Seeking Alpha
News Tags:
Optina
Regeneron
Novartis
Eylea
Ampio Pharmaceuticals
age-related macular degeneration
Lucentis
Headline:
Regeneron Shareholders Watching Optina Trial Closely
Do Not Allow Advertisers to Use My Personal information
